Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1941 1
1946 7
1947 3
1948 4
1950 1
1951 2
1952 2
1953 3
1954 4
1955 2
1956 2
1957 3
1958 2
1959 2
1960 2
1961 2
1962 3
1963 2
1964 5
1965 4
1966 1
1967 1
1968 4
1969 3
1970 6
1971 8
1972 12
1973 6
1974 4
1975 16
1976 11
1977 20
1978 18
1979 27
1980 11
1981 12
1982 16
1983 22
1984 15
1985 26
1986 22
1987 29
1988 34
1989 21
1990 35
1991 33
1992 42
1993 60
1994 31
1995 39
1996 29
1997 29
1998 36
1999 37
2000 25
2001 38
2002 30
2003 33
2004 44
2005 40
2006 54
2007 57
2008 45
2009 55
2010 43
2011 58
2012 60
2013 57
2014 53
2015 62
2016 80
2017 83
2018 70
2019 80
2020 87
2021 67
2022 76
2023 96
2024 82
2025 41

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,137 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Heartsink.
Evans B. Evans B. Aust J Gen Pract. 2024 Jan-Feb;53(1-2):5. doi: 10.31128/AJGP-02-24-1234e. Aust J Gen Pract. 2024. PMID: 38316478 Free article. No abstract available.
Challenging conversations.
Evans B. Evans B. Aust J Gen Pract. 2025 Jun;54(6):325. doi: 10.31128/AJGP-06-25-1234e. Aust J Gen Pract. 2025. PMID: 40466729 Free article. No abstract available.
Prescribing.
Evans B. Evans B. Aust J Gen Pract. 2023 Apr;52(4):167. doi: 10.31128/AJGP-04-23-5678e. Aust J Gen Pract. 2023. PMID: 37021441 No abstract available.
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.
Psyrri A, Fayette J, Harrington K, Gillison M, Ahn MJ, Takahashi S, Weiss J, Machiels JP, Baxi S, Vasilyev A, Karpenko A, Dvorkin M, Hsieh CY, Thungappa SC, Segura PP, Vynnychenko I, Haddad R, Kasper S, Mauz PS, Baker V, He P, Evans B, Wildsmith S, Olsson RF, Yovine A, Kurland JF, Morsli N, Seiwert TY; KESTREL Investigators. Psyrri A, et al. Among authors: evans b. Ann Oncol. 2023 Mar;34(3):262-274. doi: 10.1016/j.annonc.2022.12.008. Epub 2022 Dec 16. Ann Oncol. 2023. PMID: 36535565 Free article. Clinical Trial.
OXA β-lactamases.
Evans BA, Amyes SG. Evans BA, et al. Clin Microbiol Rev. 2014 Apr;27(2):241-63. doi: 10.1128/CMR.00117-13. Clin Microbiol Rev. 2014. PMID: 24696435 Free PMC article. Review.
Lip reconstruction.
Anvar BA, Evans BCD, Evans GRD. Anvar BA, et al. Among authors: evans bcd. Plast Reconstr Surg. 2007 Sep 15;120(4):57e-64e. doi: 10.1097/01.prs.0000278056.41753.ce. Plast Reconstr Surg. 2007. PMID: 17805106 Review.
Breathing.
Evans B. Evans B. Aust J Gen Pract. 2023 Sep;52(9):581. Aust J Gen Pract. 2023. PMID: 37666777 No abstract available.
2,137 results